Vycor Medical (VYCO) Income towards Parent Company (2022 - 2023)
Vycor Medical (VYCO) has disclosed Income towards Parent Company for 6 consecutive years, with -$425.0 as the latest value for Q3 2023.
- Quarterly Income towards Parent Company rose 82.97% to -$425.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was -$3517.0 through Dec 2023, down 365.83% year-over-year, with the annual reading at -$755.0 for FY2022, N/A changed from the prior year.
- Income towards Parent Company for Q3 2023 was -$425.0 at Vycor Medical, up from -$2385.0 in the prior quarter.
- The five-year high for Income towards Parent Company was $3779.0 in Q4 2022, with the low at -$2495.0 in Q3 2022.